Dimensional Fund Advisors LP Magenta Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.26 - $2.09 $6,417 - $10,644	-5,093 Reduced 3.22%	152,984 $216,000
Q2 2022 Aug 12, 2022	SELL	$0.97 - $3.08 $13,634 - $43,292	-14,056 Reduced 8.17%	158,077 $189,000
Q1 2022 May 13, 2022	SELL	$2.55 - $5.23 $19,589 - $40,176	-7,682 Reduced 4.27%	172,133 $500,000
Q4 2021 Feb 09, 2022	SELL	$4.43 - $8.33 $52,384 - $98,502	-11,825 Reduced 6.17%	179,815 $797,000
Q3 2021 Nov 12, 2021	SELL	$6.07 - $9.89 $699,664 - $1.14 Million	-115,266 Reduced 37.56%	191,640 $1.4 Million
Q2 2021 Aug 12, 2021	BUY	$9.76 - $14.15 $1.14 Million - $1.66 Million	117,059 Added 61.66%	306,906 $3 Million
Q1 2021 May 14, 2021	BUY	$7.66 - $13.38 $728,481 - $1.27 Million	95,102 Added 100.38%	189,847 $2.25 Million
Q4 2020 Feb 25, 2021	BUY	$6.1 - $7.94 $577,944 - $752,275	94,745 New	94,745 $743,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.